Skip to content
drillr.ai
Sign up

00460.HK

Sihuan Pharmaceutical Holdings Group Ltd.

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK

HKD 0.79
+2.61%
Ask drillr

  • Aug 27, 2026, 14:14 UTC

    Sihuan Pharmaceutical repurchased 10 million shares from the market on August 27, 2026, at an average price of HKD 0.8111 per share, totaling approximately HKD 8.11 million.

    Source:

  • Aug 26, 2026, 04:13 UTC

    Sihuan Pharmaceutical reported interim results for the six months ended June 2026, with revenue of RMB 1.1612 billion, up 1.3% year-on-year, and net profit of RMB 224.7 million, up 119% year-on-year, with no dividend declared.

    Source:

  • Aug 26, 2026, 04:09 UTC

    Sihuan Pharmaceutical announced that executive director, deputy CEO and CFO Miao Guili resigned effective 2026-08-26, and Che Yuxuan was appointed non-executive director and Song Xiaomi was appointed CFO.

    Source:

  • Aug 12, 2026, 13:58 UTC

    Zhenkang Medical (02697.HK) announced it won the bid for a research equipment procurement project at Yunnan Agricultural University, supplying a multi-organ multi-sensor normothermic perfusion system with built-in ventilator for 2.8 million RMB.

    Source: